Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Protara Therapeutics, Inc. has filed 805 SEC EDGAR filings since 14 Apr 2006

SEC filing history

Showing 1-25 of 800 matching filings.

Per page
25
Current page
1
SCHEDULE 13G/A File 005-88372

SCHEDULE 13G/A filing

Filing date
07 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Jul 2026
Reporting date
29 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
29 Jun 2026
Reporting date
26 Jun 2026
Next action
Verify source filing
144 File 001-36694

144 filing

Filing date
29 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jun 2026
Reporting date
15 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jun 2026
Reporting date
15 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jun 2026
Reporting date
15 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jun 2026
Reporting date
15 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jun 2026
Reporting date
15 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jun 2026
Reporting date
15 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jun 2026
Reporting date
15 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jun 2026
Reporting date
15 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
15 Jun 2026
Reporting date
12 Jun 2026
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jun 2026
Reporting date
02 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-295862

PROSPECTUS SUPPLEMENT

Filing date
28 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-295862

EFFECT filing

Filing date
22 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
20 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-295862

UPLOAD filing

Filing date
19 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88372

SCHEDULE 13G/A filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-295862

REGISTRATION STATEMENT

Filing date
14 May 2026
Reporting date
Not listed
Next action
Verify source filing
10-Q File 001-36694

QUARTERLY REPORT

Filing date
13 May 2026
Reporting date
31 Mar 2026
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
13 May 2026
Reporting date
13 May 2026
Next action
Verify source filing
DEFA14A File 001-36694

DEFINITIVE ADDITIONAL MATERIALS

Filing date
28 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-36694

ANNUAL REPORT

Filing date
28 Apr 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36694

PROXY STATEMENT

Filing date
28 Apr 2026
Reporting date
12 Jun 2026
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .